doi: 10.1158/1055-9965.EPI-08-1094 18 McLaughlinSAStaleyACViciniFThiruchelvamPHutchisonNAMendezJet al
Turn to Milliman for independent, unbiased, data-driven insights, and real-world experience to keep your health and benefit plans working for your business and your employees
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
All were prescribed basal and meal (prandial) insulin
This is perhaps the most costly outcome because you waste time, resources, and other materials chasing down a variable that turns out to be your degraded peptide
However, Noom Legit has not been shown to reverse insulin resistance, lower glucagon-like peptide-1 (GLP-1) receptor dysfunction, or restore metabolic flexibility in patients with metabolic syndrome